Apogee Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
OCTAGON CAPITAL ADVISORS LP | 05/15/2025 | 10.70 M | $14.87 M | 100.00% | 18.39% |
VR ADVISER, LLC | 05/15/2025 | 8.49 M | $317.31 M | 0.00% | 14.59% |
FMR LLC | 05/12/2025 | 7.49 M | $279.96 M | -0.08% | 12.88% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 5.49 M | $204.95 M | 21.44% | 9.43% |
BLACKROCK, INC. | 05/02/2025 | 2.91 M | $108.75 M | -4.41% | 5.00% |
RTW INVESTMENTS, LP | 05/15/2025 | 2.71 M | $101.32 M | 0.00% | 4.66% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 2.34 M | $87.41 M | -10.20% | 4.02% |
VANGUARD GROUP INC | 05/09/2025 | 2.08 M | $77.81 M | -0.71% | 3.58% |
JANUS HENDERSON GROUP PLC | 05/15/2025 | 1.79 M | $71.29 M | 58.03% | 3.08% |
MERCER GLOBAL ADVISORS INC /ADV | 05/15/2025 | 1.64 M | $61.28 M | 127.77% | 2.82% |
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 1.57 M | $58.64 M | 0.00% | 2.70% |
BRAIDWELL LP | 05/15/2025 | 1.54 M | $57.55 M | 0.00% | 2.65% |
STATE STREET CORP | 05/15/2025 | 1.31 M | $49.08 M | -10.45% | 2.26% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 1.28 M | $47.86 M | -5.48% | 2.20% |
AFFINITY ASSET ADVISORS, LLC | 05/14/2025 | 1.15 M | $43.01 M | 23.56% | 1.98% |
PERCEPTIVE ADVISORS LLC | 05/15/2025 | 1.12 M | $41.95 M | 7.21% | 1.93% |
WOODLINE PARTNERS LP | 05/15/2025 | 1.06 M | $39.64 M | 4.47% | 1.82% |
JPMORGAN CHASE & CO | 05/12/2025 | 962.63 K | $35.96 M | 2,483.90% | 1.65% |
PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2025 | 961.71 K | $35.93 M | -25.09% | 1.65% |
FRANKLIN RESOURCES INC | 05/13/2025 | 876.08 K | $32.73 M | 1.14% | 1.51% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 835.70 K | $31.23 M | 2.40% | 1.44% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 821.85 K | $30.71 M | -21.92% | 1.41% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 727.00 K | $27.16 M | 202.66% | 1.25% |
UBS GROUP AG | 05/13/2025 | 701.91 K | $26.22 M | 29.67% | 1.21% |
SIREN, L.L.C. | 05/23/2025 | 594.99 K | $22.23 M | -20.38% | 1.02% |
POLAR CAPITAL HOLDINGS PLC | 05/15/2025 | 550.00 K | $20.55 M | 100.00% | 0.95% |
MORGAN STANLEY | 05/15/2025 | 519.94 K | $19.42 M | 148.14% | 0.89% |
BARCLAYS PLC | 05/15/2025 | 498.63 K | $18.63 M | 4.59% | 0.86% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 425.88 K | $15.91 M | 303.52% | 0.73% |
JEFFERIES FINANCIAL GROUP INC. | 05/08/2025 | 421.80 K | $15.76 M | -52.47% | 0.72% |
POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 392.49 K | $14.66 M | 29.65% | 0.67% |
NORTHERN TRUST CORP | 05/13/2025 | 314.48 K | $11.75 M | -3.92% | 0.54% |
JENNISON ASSOCIATES LLC | 05/05/2025 | 293.76 K | $10.97 M | -5.97% | 0.50% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 290.70 K | $10.86 M | -28.75% | 0.50% |
COMMODORE CAPITAL LP | 05/15/2025 | 290.00 K | $10.83 M | 0.00% | 0.50% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 271.88 K | $10.16 M | -2.02% | 0.47% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 260.34 K | $9.73 M | 99.99% | 0.45% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 252.14 K | $9.42 M | -5.38% | 0.43% |
VICTORY CAPITAL MANAGEMENT INC | 05/02/2025 | 232.98 K | $8.70 M | 4.45% | 0.40% |
FIRST TURN MANAGEMENT, LLC | 05/15/2025 | 229.68 K | $8.58 M | -9.12% | 0.39% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 214.23 K | $8.00 M | 93.30% | 0.37% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 200.00 K | $7.47 M | 100.00% | 0.34% |
CAPITAL WORLD INVESTORS | 05/12/2025 | 193.90 K | $7.24 M | -5.46% | 0.33% |
BLACKSTONE INC. | 05/15/2025 | 183.75 K | $6.86 M | 129.68% | 0.32% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 167.99 K | $6.28 M | 308.68% | 0.29% |
CAPTION MANAGEMENT, LLC | 05/15/2025 | 151.30 K | $5.65 M | 505.20% | 0.26% |
05/06/2025 | 127.21 K | $4.75 M | -11.63% | 0.22% | |
05/15/2025 | 126.30 K | $4.72 M | 100.00% | 0.22% | |
BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 112.73 K | $4.21 M | 100.00% | 0.19% |
05/12/2025 | 110.86 K | $4.14 M | 100.00% | 0.19% |
Apogee Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 169 institutional investors and hedge funds held shares of Apogee Therapeutics, Inc.. The most heavily invested institutionals were:
Octagon Capital Advisors LP: 10.7 M
VR Adviser, LLC: 8.49 M
FMR LLC: 7.49 M
WELLINGTON MANAGEMENT GROUP LLP: 5.49 M
BlackRock, Inc.: 2.91 M
RTW INVESTMENTS, LP: 2.71 M
120.52% of Apogee Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 73.48 M shares in the last 24 months. This purchase volume represents approximately $2.82 B in transactions.